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Neil J Glassford1,2, Glenn M Eastwood1,3 and Rinaldo Bellomo1,2*Abstract
Fluid bolus therapy (FBT) is a standard of care in the management of the septic, hypotensive, tachycardic and/or
oliguric patient. However, contemporary evidence for FBT improving patient-centred outcomes is scant. Moreover,
its physiological effects in contemporary ICU environments and populations are poorly understood. Using three
electronic databases, we identified all studies describing FBT between January 2010 and December 2013. We found
33 studies describing 41 boluses. No randomised controlled trials compared FBT with alternative interventions, such
as vasopressors. The median fluid bolus was 500 ml (range 100 to 1,000 ml) administered over 30 minutes (range
10 to 60 minutes) and the most commonly administered fluid was 0.9% sodium chloride solution. In 19 studies, a
predetermined physiological trigger initiated FBT. Although 17 studies describe the temporal course of physiological
changes after FBT in 31 patient groups, only three studies describe the physiological changes at 60 minutes, and only
one study beyond this point. No studies related the physiological changes after FBT with clinically relevant outcomes.
There is a clear need for at least obtaining randomised controlled evidence for the physiological effects of FBT in patients
with severe sepsis and septic shock beyond the period immediately after its administration.
? Just as water retains no shape, so in warfare there are no constant conditions?
Sun Tzu (? The Art of War? )Introduction
All critically ill patients receive intravenous (IV) fluids, which
are given to maintain physiological homeostasis, or as
a vehicle for drug administration, or as direct therapeutic
administration to correct perceived haemodynamic
instability [1-4]. In these situations, where there is a
perceived reduction in venous return and cardiac
output secondary to vasodilatation and/or hypovolaemia,
using IV fluid to increase intravascular volume is believed
to effectively compensate for these changes in vascular
tone by increasing stroke volume in accordance with the
Frank-Starling principle [5-10].
Several mechanisms for delivering IV fluids, both diag-
nostically and therapeutically under such circumstances,
have been described. These include Weil? s central venous
pressure (CVP)-guided fluid challenge technique [10-13],* Correspondence: rinaldo.bellomo@austin.org.au
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unless otherwise stated.the timed and rapid infusion methods favoured by
Shoemaker [7,8,14-16] and, more recently, techniques
involving echocardiographic or ultrasonographic assessment
of fluid responsiveness following low-volume IV infusion
[17]. However, the current standard of care in the
management of septic, hypotensive, tachycardic and/or
oliguric patients is fluid bolus therapy (FBT), where IV
fluid is rapidly administered in discrete boluses [18-21].
While the ideal fluid bolus would be a discrete volume of
a specific fluid administered at a specified rate, accounting
for individual patient features and with a defined aim
(Figure 1) [11], there is no current agreement regarding
exactly what defines a fluid bolus. Moreover, although
strong overall consensus regarding the importance of FBT
exists [18-20], there appears to be little randomized
controlled information on the magnitude and duration of
its physiological effects, or on the direct positive impact
of FBT on patient outcome in sepsis as an independent
intervention [22].
In contrast, an expanding body of evidence suggests
that FBT may contribute to a positive fluid balance,
which, in turn, is independently associated with a variety
of adverse outcomes in the critically ill [23-28]. RecentLtd. The licensee has exclusive rights to distribute this article, in any medium,
this time, the article is available under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Describing the concept of idealised fluid bolus therapy. (A) Diagram describing the key criteria defining the concept of a fluid
bolus. (B) Diagram describing the idealised concept of fluid bolus therapy in critical care, including purpose, triggers, end-points and purported
physiological effects of such resuscitation.
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can also damage the endothelial glycocalyx [29,30], a
structure already at risk in patients with sepsis [31],
leading to endothelial disruption and organ dysfunction
[32,33]. It appears that we need a better understanding of
both the current evidence base for FBT and how best to
apply it in the clinical setting [34,35].
Accordingly, we systematically reviewed the contempor-
ary literature to determine current practice and to identifyFigure 2 Electronic search strategy. Diagrammatic representation of the
sepsis and clinical studies, along with predetermined limitations.the independent effects of FBT on both physiological and
patient-centred outcomes in the management of severe
sepsis and septic shock in critical care practice.
Methods
We interrogated the MEDLINE, CENTRAL and EMBASE
electronic reference databases using a combination of search
terms (Figure 2). The reference lists of retrieved articles
were examined for additional studies of potential relevance.search strategy combining terms representing fluid resuscitation,
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contemporary relevance results were arbitrarily limited to
this decade (2010 to 2013) and to English language studies
in humans. Paediatric studies were excluded. This search
defined a set of records of studies of fluid administration or
haemodynamic optimization in patients with severe sepsis
or septic shock.
The abstracts of these records were examined to identify
those studies of potential relevance. These manuscripts
were retrieved and examined manually in accordance with
our inclusion criteria. The studies to be included in the
review were checked to ensure they had not been retracted
subsequent to their publication.
Study inclusion criteria
Population of included studies
We considered clinical studies of any type describing a
population of patients suffering from severe sepsis or
septic shock. We also included those studies of shock
or circulatory failure where either the majority of patients,
or a defined subgroup of patients, had severe sepsis or
septic shock.
Intervention - fluid bolus administration
For the purposes of this study a fluid bolus was a defined
volume of a defined fluid administered over a defined
time period. We recognised that most studies do not
describe FBT in ideal terms (Figure 1) and therefore
studies describing at least two of the three criteria were
included in the review.
Comparator - alternatives to fluid administration
Any studies comparing FBT with the initiation of vasoactive
medication, the increase of such medication or observation
as an alternative to the administration of FBT were included
in the review.
Between groups analysis
Where studies included in the review assigned patients
to multiple treatment arms, each treatment group was
treated as an individual group.
Outcome - physiological effects of bolus administration
Subsets of studies were selected from those describing
FBT. The first included those reporting changes in cardiac
output, heart rate, mean arterial pressure, central venous
pressure, venous oxygen saturation, blood lactate concen-
tration, urine output or haemoglobin concentration
following FBT; for the purposes of inclusion, studies could
describe changes in any or all of the haemodynamic
parameters listed, but the direction, magnitude and
duration of the change had to be extractable from tables
or figures contained in the paper. The second group
included those reporting non-physiological, patient-centredoutcomes. Our primary outcome of interest was mortality
at all reported time points. Secondary outcomes of interest
included duration of ICU and hospital stay, duration of
mechanical ventilation, and need for continuous renal
replacement therapy (CRRT). We did not contact authors
for additional information or individual patient data.
Data collection
We collected data on study type, study setting and location,
study population and the aims of the study. Due to our
acceptance of multiple types of study, we chose not to
adopt a methodological scoring system. We examined the
definition of a fluid bolus in each study fulfilling our criteria
and recorded the type and volume of fluid used, as well as
the rate of administration. We identified the trigger and
end-points for fluid bolus administration, the number of
boluses administered and the use of red cell transfusions
and vasoactive medication as part of the experimental
protocol. We identified the demographic group in which
subsequent observations were recorded. In those studies
describing the physiological effects of bolus administration,
we recorded the absolute change in cardiac output, heart
rate, mean arterial pressure, venous oxygen saturation,
blood lactate concentration, urine output and haemoglobin
concentration. In those studies reporting patient-centred
outcomes we recorded mortality at all reported time points,
duration of ICU and hospital stay, duration of mechanical
ventilation, and need for CRRT.
Statistical analysis
We expected grossly heterogeneous results across different
study types and study protocols. A meta-analysis approach
could not be applied. Results are therefore presented as
crude medians with full ranges. These exclude alternative
units of measure, which are reported separately - for
example, the median may be given in millilitres, followed
by individual reporting of ml/kg.
Results
Electronic search
Our search strategy identified 2,956 articles over the
period 2010 to 2013. Of these, 2,875 were excluded as
duplicates, irrelevant, paediatric research or having been
published in a language other than English. Of the 81
potentially relevant publications identified, 33 met our
inclusion criteria (Figure 3) [36-68]. In total, 17 of these
described the physiological changes occurring following
FBT [36,39,40,45,46,48,50,53-55,57,59,60,62,63,65,66] and
seven studies described patient-orientated outcome mea-
sures [37,42,43,49,58,59,64].
Relevant contemporary studies
The study details, population, size and aims are presented
in Table 1. We identified 22 prospective observational
Figure 3 Study selection. Flow diagram of the study selection process and detailed description of study exclusions. FBT, fluid bolus therapy.
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quasi-experimental studies, and five randomised controlled
trials (RCTs). Of the five RCTs, none compared FBT with a
control intervention; two actually reported the impact of
blood volume analysis on protocolized resuscitation [64,67];
two compared hypertonic versus isotonic fluids [51,65];
and one actually compared two vasopressors and re-
ported fluid data as an addendum [38]. Additional
study data can be found in the electronic supplemen-
tal material (Additional file 1: Table S1).Pre-fluid bolus therapy fluid administration
Fluid resuscitation prior to study recruitment and FBT
was described in 10 studies. In the five studies describing
finite volumes of resuscitation fluid, the median volume
administered was 2,200 ml (range 1,000 to 5,060 ml)
[38,47,51,53,58]. The five remaining studies reported
weight-dependent volumes of between 20 and 30 ml/kg of
resuscitation (Table 2) [41,43,49,56,57].Initiation and cessation of fluid bolus therapy
Across the 33 studies, 19 predetermined clinical or
physiological features triggered FBT. In the remaining
14 studies, FBT was triggered by clinical judgment in
eight, by ? hypotension ? in two, simply by the diagnosis
of severe sepsis or septic shock in two, and remained
unspecified in two (Table 2).
In the majority of studies (18 of 33) FBT ceased at the
end of the bolus in question; 10 studies used predetermined
immediate changes in physiological variables as end-points;
four studies did not define the physiological end-points of
fluid resuscitation (Table 2).Defining fluid bolus therapy
Overall, 41 forms of FBT were described, fully or in part,
in 33 studies. They are presented in Table 2. In 20 studies,
the fluid type was fixed; in 13 more than one fluid type
was used. In six studies the fluid type was not identified
beyond the generic ?crystalloid or colloid? . The fluid most
commonly used as a bolus was 0.9% saline (17 studies),
followed by 6% hydroxyethyl starch (eight studies). On the
other hand, 4% albumin was used in only four studies
[38,53,59,65], 4% gelatin in only three [38,48,66],
physiological lactated solutions in only two [59,61], and
20% albumin and blood products in only one [38].
The median amount of fluid administered as a finite
volume was 500 ml (range 100 to 1,000 ml). However,
20 ml/kg and 7 ml/kg were individually reported as
weight-dependent boluses. The median number of boluses
(24 studies) was 1 (range 0.68 to 10). Rates of administra-
tion were defined for 31 of 41 boluses with a median rate
of 30 minutes (range 10 to 60 minutes).
Haemodynamic changes after fluid bolus therapy
Comparing different interventions
No RCTs compared the haemodynamic changes induced
by FBT with ? observation? or ? vasopressor administration? or
? inotropic drug administration? or ?continuous low dose IV
fluid infusion? or any combination of the above. The only
study comparing FBT with an alternative intervention was
a single, non-randomized, prospective, observational study
that compared acute circulatory failure patients treated with
FBT (500 ml of saline) or with increased norepinephrine
dose according to clinician preference [55]. The two groups
had clearly different baseline characteristics and were not
directly compared.
Table 1 Study settings, size, population and aims
First author Journal Year Aims of study Location Institution(s) Study type Population size
Bihari [36] Shock 2013 Investigation of the use and effects
of fluid boluses in septic patients
following primary resuscitation
Australia Single centre,
academic ICU
Prospective
observational
study
50 patients with severe sepsis
or septic shock
Castellanos-Ortega [37] Critical Care Medicine 2010 Evaluation of the impact of a
standardised EGDT response to sepsis
Spain Single centre,
academic ICU
Quasi-experimental
study
480 patients with septic shock
De Backer [38] New England Journal
of Medicine
2010 Assessing the effect of noradrenaline
as first-line vasopressor on mortality
Europe 8 centres,
mixed ICUs
Randomised
clinical trial
1,679 patients with shock requiring
vaspressor therapy. 1,044 patients
with sepsis
Dong [39] World Journal of
Emergency Medicine
2012 Investigating the relationship
between stroke volume index
and passive leg raising and fluid
responsiveness
China 2 centres,
general ICUs
Prospective
observational
study
32 mechanically ventilated patients
with septic shock
Freitas [40] British Journal of Anaesthesia 2013 Evaluation of the predictive value
of automated PPV for fluid
responsiveness in patients with
sepsis and low tidal volumes
Brazil Single centre,
academic ICU
Prospective
observational
study
40 patients with low tidal volume
ventilation and severe sepsis or septic
shock requiring a fluid challenge
Gaieski [41] Critical Care Medicine 2010 Evaluation of the impact of a
standardised EGDT response to
sepsis on time to antibiotic
administration and survival
USA Single centre,
academic ICU
Retrospective
observational
study
261 patients with severe sepsis and
septic shock undergoing EGDT
Hamzaoui [42] Critical Care 2010 Evaluation of the cardiac
consequences of early
administration of noradrenaline
France Single centre,
academic ICU
Prospective
observational
study
105 patients with septic shock
requiring vasopressor commencement
following initial fluid resuscitation
Hanzelka [43] Supportive Care in
Cancer
2013 Evaluation of the impact of a
standardised EGDT response
to sepsis
USA Single centre,
academic ED
Retrospective
observational
study
200 patients with cancer and severe
sepsis or septic shock presenting to ED
Jacob [44] Critical Care Medicine 2012 Evaluation of the impact of
early monitored sepsis
management
Uganda 2 centres,
medical/treatment
centres
Prospective
observational
study
671 patients with severe sepsis
presenting within office hours
Khwannimit [45] European Journal of
Anaesthesiology
2012 Comparing SVV by Vigileo with
PPV by monitor to predict
fluid responsiveness
Thailand Single centre,
academic ICU
Prospective
observational
study
42 patients with septic shock who
were mechanically ventilated with
tidal volumes >8 ml/kg requiring
fluid resuscitation
Lakhal [46] Intensive Care Medicine 2013 Identification of fluid
responsiveness from IABP
and NIBP
France 3 centres,
academic ICU
Prospective
observational
study
130 patients with circulatory failure
requiring a fluid challenge. 58
patients with septic shock
Lanspa [47] Journal of Critical Care 2012 Assessment of CVP and shock
index to predict haemodynamic
response to volume expansion
when compared with CVP alone
USA Single centre,
academic ICU
Prospective
observational
study
25 patients with septic shock over
14 years of age
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Table 1 Study settings, size, population and aims (Continued)
Machare-Delgado [48] Journal of Intensive
Care Medicine
2011 Predicting fluid responsiveness
by comparing SVV and inferior
vena caval respiratory variation
by ECHO during mechanical
ventilation
USA Single centre,
medical
academic ICU
Prospective
observational
study
25 mechanically ventilated
vasopressor-dependent patients
who required a fluid challenge.
22 patients with severe sepsis or
septic shock
MacRedmond [49] Quality and Safety
in Health Care
2010 Evaluation of the impact of
implementing a quality initiative
on the management of severe
sepsis and septic shock
Canada Single centre, ICU Quasi-experimental
study
74 patients with severe sepsis or
septic shock admitted via ED
Mahjoub [50] Intensive Care Medicine 2012 Assessment of the impact of
volume expansion on patients
with left ventricular dysfunction
France Single centre,
academic ICU
Prospective
observational
study
83 mechanically ventilated patients
with sepsis-induced circulatory failure
McIntyre [51] Journal of Critical Care 2012 Feasibility study comparing the
effects of 5% albumin versus 0.9%
saline for resuscitation in septic shock
Canada 6 centres,
academic
ED and ICU
Randomised
clinical trial
50 patients with refractory hypotension
and sepsis
Monnet [52] Critical Care 2010 Comparing haemodynamic changes
induced by noradrenaline and volume
expansion using Vigileo and PiCCO
France Single centre,
academic
medical ICU
Prospective
observational
study
80 patients with sepsis-induced
circulatory failure
Monnet [53] Critical Care Medicine 2011 Assessing the effects of noradrenaline
on haemodynamics in sepsis
France Single centre,
academic
medical ICU
Prospective
observational
study
25 patients with sepsis-induced
fluid-responsive acute circulatory
failure with DBP <40 mmHg, or
requiring noradrenaline
Monnet [54] Critical Care Medicine 2013 Comparing ScvO2 and markers of
anaerobic metabolism as predictors
of unfavourable changes in oxygen
extraction
France Single centre,
academic
medical ICU
Prospective
observational
study
51 patients with acute circulatory
failure undergoing transpulmonary
thermodilution monitoring, 40
patients with septic shock
Monnet [55] Critical Care Medicine 2011 Investigation of the utility of pulse
pressure as a surrogate for changes
in cardiac output
France Single centre,
academic
medical ICU
Prospective
observational
study
373 patients with acute circulatory
failure requiring a fluid challenge or
the introduction or dose increase
of noradrenaline. 338 patients
with septic shock
O ?Neill [56] Journal of Emergency
Medicine
2012 Evaluation of the most difficult
elements of a SSC protocol to
implement in a community-based ED
USA Single centre,
community ED
Retrospective
observational
study
79 with severe sepsis or septic
shock remaining hypotensive
following 2,000 ml of fluid
resuscitation
Ospina-Tascon [57] Intensive Care Medicine 2010 Evaluation of the effects of fluid
administration on microcirculatory
alterations in sepsis
Belgium Single centre,
academic ICU
Prospective
observational
study
60 patients with severe sepsis
requiring fluid challenge. 37
within 24 hours of diagnosis,
23 after 48 hours
Patel [58] Annals of
Pharmacotherapy
2010 Investigation of the implementation
and effects of introducing the
SSC guidelines
USA Single centre,
community ICU
Prospective
observational
study
112 patients with sepsis or
septic shock
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Pierrakos [59] Intensive Care Medicine 2012 Evaluation of the correlation
between changes in MAP and
CI following fluid challenge
Belgium Single centre,
academic ICU
Prospective
observational
study
51 patients with septic shock
undergoing invasive haemodynamic
monitoring and requiring a fluid
challenge
Pottecher [60] Intensive Care Medicine 2010 Assessment of sublingual
microcirculatory changes in
response to fluid challenge
France 2 centres,
academic ED
Prospective
observational
study
25 mechanically ventilated patients
with severe sepsis or septic shock
within 24 hours of ICU admission
demonstrating pre-load dependency
Sanchez [61] Anaesthesia and
Intensive Care
2011 Measuring the response to a
fluid load in patients with and
without septic shock
Spain Single centre,
academic ICU
Prospective
observational
study
32 patients requiring invasive
monitoring. 18 patients with
septic shock
Schnell [62] Critical Care Medicine 2013 Assessment of the effects of a
fluid challenge on Doppler-based
renal resistive index in critically ill
patients
France 3 centres,
academic ICUs
Prospective
observational
study
35 mechanically ventilated
patients with real-time cardiac
monitoring requiring a fluid
challenge. 30 patients with sepsis
Sturgess [63] Anaesthesia and
Intensive Care
2010 Comparison of aortic corrected
flow time, BNP and CVP as
predictors of fluid responsiveness
Australia Single centre,
private ICU
Prospective
observational
study
10 patients with septic shock
requiring a fluid challenge
Trof [64] Critical Care Medicine 2012 Comparison of volume-guided
and pressure-guided hemodynamic
management in shocked patients
Netherlands 2 centres,
academic, ICU
Randomised
clinical trial
120 patients with shock requiring
invasive haemodynamic monitoring
and >48 hours of ICU admission.
72 patients with sepsis
van Haren [65] Shock 2012 Evaluation of the effects of hypertonic
versus isotonic fluid administration
in patients with septic shock
Netherlands Single centre,
academic ICU
Randomised
clinical trial
24 patients with septic shock
enrolled within 24 hours of
admission
Wacharasint [66] Journal of the Medical
Association of Thailand
2012 Evaluation of the effectiveness of
three dynamic measures of fluid
responsiveness in septic shock patients
Thailand Single centre,
medical ICU
Prospective
observational
study
20 patients with sepsis and acute
circulatory failure with invasive
haemodynamic monitoring stable
for 15 minutes prior to inclusion
Yu [67] Shock 2011 Evaluation of the effects of blood
volume analysis compared with
pulmonary artery catheter monitoring
North America Single centre,
academic ICU
Randomised
clinical trial
100 patients requiring resuscitation
for shock. 69 patients with severe
sepsis or septic shock
Zhang [68] Journal of Critical Care 2012 Investigation of the association
between plasma protein levels
and subsequent pulmonary oedema
China Single centre,
academic ICU
Retrospective
observational
study
62 patients with sepsis undergoing
transpulmonary thermodilution
assessment requiring fluid
BNP, B-type natriuretic peptide; CI, cardiac index; CVP, central venous pressure; DBP, diastolic blood pressure; ECHO, echocardiogram; ED, Emergency Department; EGDT, early goal directed therapy; IABP, intra-arterial
blood pressure; MAP, mean arterial blood pressure; NIBP, non-invasive blood pressure; PiCCO, pulse contour cardiac output monitoring; PPV, pulse pressure variation; ScvO2, central venous oxygen saturation; SSC,
Surviving Sepsis Campaign; SVV, stroke volume variation.
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Table 2 Description of fluid boluses, triggers, physiological end-points and primary confounders
First author Year Initial
resuscitation
Bolus fluid
type
Bolus fluid
volume (ml)
Bolus fluid
rate (minutes)
Physiological trigger for
fluid administration
Physiological
end-point for fluid
administration
Number of
boluses
administered
Vasoactive
administration?
Packed red
cell transfusion?
Bihari [36] 2013 Undefined 4% albumin 750 <30 Clinician defined Clinician defined 2 Yes Not described
Packed
red cells
20% albumin
Fresh frozen
plasma
4% gelatin
0.9% saline
Castellanos-
Ortega [37]
2010 Undefined Crystalloid 1,000 30 Hypotension CVP ≥8 mmHg,
MAP ≥65 mmHg,
ScvO2 ≥ 70%
Not described Yes Not described
Colloid 500
De Backer [38] 2010 500 ml colloid or
1,000 ml crystalloid
Crystalloid 1,000 Not defined MAP <70 mmHg; SBP
<100 mmHg, altered
mental state; mottled
skin; oliguria >1 hour,
hyperlactataemia
Not described Not described Yes Not described
Colloid 500
Dong [39] 2012 Undefined 6% HES 500 30 SBP <90 mmHg or
>40 mmHg drop
or need for
vasopressors,
oliguria >1 hour;
mottled skin; HR
>100 bpm
End of infusion. 1 Not described Not described
Freitas [40] 2012 Undefined 6% HES 7 ml/kg
(max 500)
30 Clinician defined End of infusion 1 Yes No
Gaieski [41] 2010 20-30 ml/kg 0.9% saline 500 15-20 CVP <8 mmHg CVP >8 mmHg Not described Yes Yes
Hamzaoui [42] 2010 Undefined 0.9% saline 1,000 Not defined Undefined Not described Not described Yes Not described
Hanzelka [43] 2013 20 ml/kg Undefined 1,000 60 Severe sepsis SBP >90 mmHg,
MAP <65 mmHg
Not described Yes No
500 30
Jacob [44] 2012 Undefined 0.9% saline 1,000 60 SBP <100 mmHg
or hyperlactataemia
SBP increased by
10 mmHg for 2
consecutive hours
to >90 mmHg
Up to 10 No Not described
500 30
Khwannimit [45] 2012 Undefined 6% HES 500 30 Clinician defined End of infusion 1 Yes Not described
Lakhal [46] 2013 Undefined 4% gelatin 500 30 One or more of SBP
<90 mmHg, MAP
<65 mmHg , requiring
vasoactive medication,
oliguria, skin mottling,
hyperlactataemia
End of infusion 1 Yes Not described
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Table 2 Description of fluid boluses, triggers, physiological end-points and primary confounders (Continued)
Lanspa [47] 2012 5,060 ml Crystalloid
(or equivalent
colloid)
20 ml/kg <20 Clinician defined End of infusion 1.36 Yes Yes
Machare-Delgado
[48]
2011 Undefined 0.9% saline 500 10 Clinician defined End of infusion 1 Not described No
MacRedmond
[49]
2010 25 ml/kg 0.9% saline 500 <15 MAP <65 mmHg CVP 8-12; MAP
>65 mmHg;
ScvO2 > 70%
Not described Yes Yes
Mahjoub [50] 2013 Undefined 0.9% saline 500 20 SBP <90 mmHg and/or
need for vasoactive
drugs and/or persistent
lactic acidosis
End of infusion 1 Yes Not described
McIntyre [51] 2012 2,400 ml 0.9% saline or
4% albumin
500 STAT Undefined Not described 6 Yes Not described
Monnet [52] 2010 Undefined 0.9% saline 500 30 SBP <90 mmHg, SBP
drop >50 mmHg if HT,
and one or more of
HR >100, skin mottling
or oliguria
End of infusion 1 Yes Not described
Monnet [53] 2011 2,200 ml 0.9% saline 500 10 SBP <90 mmHg, SBP
drop >50 mmHg if HT,
and one or more of HR
>100, skin mottling or
oliguria
End of infusion 1 Yes Not described
Monnet [54] 2013 Undefined 0.9% saline 500 30 SBP <90 mmHg, SBP
drop >50 mmHg if HT,
and one or more of HR
>100, skin mottling or
oliguria
End of infusion 1 Yes Yes
Monnet [55] 2011 Undefined 0.9% saline 500 20 SBP <90 mmHg, SBP
drop >50 mmHg if HT,
and one or more of
HR >100, skin mottling
or oliguria
End of infusion 1 Yes Not described
O ?Neill [56] 2012 20 ml/kg 0.9% saline 500 15 CVP <8 mmHg;
MAP <65 mmHg;
ScvO2 < 70%
CVP 8-12; MAP
>65 mmHg;
ScvO2 > 70%
0.68 Yes Not described
Ospina-Tascon
[57]
2010 Undefined CSL 1,000 30 MAP <65 mmHg End of infusion 1 Yes Not described
4% albumin 400
Patel [58] 2010 2,000 ml Normal saline Undefined 30 SBP <90 mmHg;
MAP <65 mmHg
Not described 1 Yes Not described
Pierrakos [59] 2012 Undefined CSL 100 30 Clinician defined End of infusion 1 Yes Not described
6% HES 500
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Table 2 Description of fluid boluses, triggers, physiological end-points and primary confounders (Continued)
Pottecher [60] 2010 Undefined HES 6% or
0.9% saline
500 30 MAP <65 mmHg, skin
mottling or oliguria
End of infusion 1 Yes Not described
Sanchez [61] 2011 Undefined Crystalloid 1,000 Undefined Hypotension with
perfusion abnormalities
Not described Yes No
Colloid 500 ITBVI >900 ml/ml
or EVLWI >10 ml/kg
Schnell [62] 2013 Undefined 0.9% saline 500 15-30 Clinician defined End of infusion 1 Yes Not described
Sturgess [63] 2010 Undefined 4% albumin 250 15 Clinician defined End of infusion 1 Yes No
Trof [64] 2012 Undefined HES or 4%
gelatin
250-500 30 EVLWI <10 ml/kg or
>10 ml/kg with GEDVI
<850 ml/m2; PAOP
>18 mmHg; MAP
<65 mmHg, HR
>100, SvO2 < 65%
or ScvO2 < 70%;
oliguria; peripheral
perfusion deficits,
hyperlactatemia
MAP >65 mmHg,
ScvO2 > 70%, lactate
clearance, diuresis
>0.5 ml/kg/hour,
restoration of
peripheral
perfusion deficits
3.48 Yes Not described
van Haren [65] 2012 Undefined 6% HES in
0.9% saline
500 15 Septic shock End of infusion 1 Yes Not described
250 15
6% HES in
7.2% saline
Wacharasint [66] 2013 Undefined HES 6% 500 30 SBP <90 mmHg or
requirement for
vasopressors
End of infusion 1 Yes Not described
Yu [67] 2011 30 ml/kg
in 1,000 ml
increments
Crystalloid
or colloid
250-500 Undefined PAOP <12 mmHg or
12-17 mmHg with
SBP >100 mmHg,
HR <100 bpm,
UO >0.5 ml/kg/hour,
lactate clearance,
SmvO2 > 70%
Not described Not described Yes
SBP <100;
HR >100 bpm
UO <0.5 ml/kg/hour;
hyperlactataemia; SvO2
> 70% or equivalent
blood volume goals
Zhang [68] 2012 Undefined Crystalloid
or colloid
250-500 30 SBP <90 mmHg; HR
>100 bpm; GEDVI
<700 ml/m2; CVP
<12 mmHg (PEEP
dependent)
Pre-defined
rise in CVP
Not described Yes Not described
CSL, compound sodium lactate solution; CVP, central venous pressure; EVLWI, extra-vascular lung water index; HES, hydroxyethyl starch; HR, heart rate; HT, hypertensive; GEDVI, global end diastolic volume index; ITBVI,
intrathoracic blood volume index; MAP, mean arterial blood pressure; PAOP, pulmonary artery occlusion pressure; PEEP, positive end-expiratory pressure; SBP, systolic blood pressure; ScvO2, central venous oxygen
saturation; SmvO2, mixed venous oxygen saturations; STAT, statim/immediately; SvO2, venous oxygen saturation; UO, urine output.
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bolus therapy
The temporal change in physiological parameters follow-
ing FBT is described in 31 different groups across 17
studies (Table 3).Immediately post-infusion
Ten studies reported the physiological state after bolus ad-
ministration in 18 groups immediately post-administration.
In the six studies describing changes in cardiac index
immediately post-FBT, cardiac index increased by a
median of 800 ml/minute/m2 (range 0 to 1,300 ml/mi-
nute/m2). The median reduction in heart rate at the
end of a fluid bolus (eight studies) was 2 bpm (range
10 to 0 bpm reduction) and the median increase in
mean arterial pressure (eight studies) was 7 mmHg
(range 1 to 15.2 mmHg). The median increase in CVP
across five studies was 3.2 mmHg (range 2.3 to
5.2 mmHg). Only a single study reported the effect on
venous oxygen saturation, blood lactate concentration
or haemoglobin concentration. No study reported the
effect on urine output.Thirty minutes post-administration
Five studies reported the physiological effects of FBT
30 minutes after administration. Cardiac index increased
by a median of 300 ml/minute/m2 (range -400 to
600 ml/minute/m2) in three studies. The median reduc-
tion in heart rate (five studies) was 2 bpm (range
11 bpm reduction to 0.3 bpm increase) and the median
increase in mean arterial pressure (five studies) was
7.5 mmHg (range 3 to 11 mmHg). The median increase
in CVP across four studies was 3 mmHg (range 2 to
5.25 mmHg). There was a median increase in central
venous saturation of 2% (range 4% reduction to 8% in-
crease) across two studies. Changes in other indices are
reported in Table 3.Sixty minutes post-administration
Only three studies reported the physiological effects
of FBT 60 minutes after administration (Figure 4)
[36,57,65]. Cardiac index increased by a median of
300 ml/minute/m2 (range -300 to 400 ml/minute/m2) in
two studies. The median reduction in heart rate 60 mi-
nutes after a fluid bolus (three studies) was 1 bpm (range
11 bpm reduction to 2 bpm increase) and the median in-
crease in mean arterial pressure (three studies) was
3 mmHg (range 2 to 7 mmHg). The median increase in
CVP across three studies was 2 mmHg (range 1 to
3 mmHg). There was a median increase in central ven-
ous saturation of 1% (range 0.4% to 2% increase) across
two studies.Beyond 1 hour post-fluid bolus therapy
Only one study reported the effects of BFT at 120, 180
and 240 minutes after administration (Figure 4) [65].
Comparing responders and non-responders
Overall, 10 studies compared the physiological responses
to FBT administration between groups defined by
changes in a physiological variable. Patients were defined
as either responders or non-responders depending on
the response exhibited. Different variables are used in
different studies: stroke volume index (five studies), car-
diac index or output (three studies), increase in oxygen
consumption (one study) or aortic blood flow rate (one
study). All reported changes only within 30 minutes of
FBT completion (Additional file 1: Table S2).
In the six studies describing changes in cardiac index,
cardiac index increased by a median of 850 ml/minute/
m2 (range 600 to 1,300 ml/minute/m2) in fluid re-
sponders compared with 200 ml/minute/m2 (range 0 to
1,000 ml/minute/m2) in non-responders. The median in-
crease in mean arterial pressure (10 studies) in re-
sponders was 9.5 mmHg (range 7 to 15.2 mmHg) versus
4.8 mmHg (range 1 to 13 mmHg) in non-responders.
Similarly, the median increase in central venous pressure
(six studies) was 3 mmHg (range 2.6 to 3.4 mmHg) in
responders versus 3.7 mmHg (range 2 to 5.2 mmHg) in
non-responders. The median decrease in heart rate (nine
studies) was 3.3 bpm in responders (range 1.5 to 10 bpm
decrease) and 1.2 bpm in non-responders (range 0 to
4 bpm decrease). Information on changes in venous oxy-
gen saturation, blood lactate concentration, and blood
haemoglobin concentration in the few studies reporting
such data are presented in Additional file 1: Table S2.
Additional comparisons
The physiological effects of FBT grouped by speed of
FBT delivery (Additional file 1: Table S3) and by class of
fluid administered (Additional file 1: Table S4) have also
been presented. There is no consistent pattern demon-
strated across or between groups.
Relationship between physiological changes after fluid
bolus therapy and clinical outcome
Overall, seven studies described clinically orientated out-
comes [37,43,44,49,58,59,64]. All reported the effects of
complex interventions, such as early goal-directed ther-
apy. No studies examined the relationship between FBT
and outcome directly (Tables 4 and 5).
Discussion
We examined the contemporary literature on FBT in se-
vere sepsis and septic shock and identified 33 original
studies describing the characteristics of a fluid bolus, 17
of which also describe the associated physiological
Table 3 Physiological effects grouped by measurement time
First author Fluid given Group Time from completion
of fluid administration
until physiological
measurement (minutes)
Measure
of central
tendency
Change in
cardiac output
estimation
Change in
heart rate
(bpm)
Change
in mean
arterial
pressure
(mmHg))
Change
in central
venous
pressure
(mmHg)
Chan e
in ve us
oxyg
satur ion (%)
Change
in blood
lactate
concentration
(mmol/l)
Change
in urine
output
Change in
haemoglobin
concentration
(g/L)
Haemodynamic indices measured immediately following fluid bolus administration
Machare-
Delgado [48]
500 ml of 0.9%
saline over
10 minutes
Responders:
>10% SVI
increase
0 Mean +3.99 ml/
m2/beat
500 ml of 0.9%
saline over
10 minutes
Non-responders:
>10% SVI
increase
0 Mean +0.57 ml/
m2/beat
Dong [39] 500 ml of 6%
HES over
30 minutes
Responders:
>15% SVI
increase
0 Mean +600 ml/
min/m2
-1.5 +15.2 +3.2
500 ml of 6%
HES over
30 minutes
Non-responders:
<15% SVI
increase
0 Mean +300 ml/
min/m2
-1.2 +4.8 +2.3
Khwannimit
[45]
500 ml of 6%
HES over
30 minutes
Responders:
>15% SVI
increase
0 Mean +1300 ml/
min/m2
-3.3 +9.5 +3.4
500 ml of
6% HES over
30 minutes
Non-responders:
<15% SVI
increase
0 Mean +200 ml/
min/m2
-0.9 +3.9 +5.2
Lakhal [46] 500 ml of 4%
gelatin over
30 minutes
Responders:
>15% SVI
increase
0 Mean +900 ml/
min/m2
-6 +14 +3
500 ml of 4%
gelatin over
30 minutes
Non-responders:
<15% SVI
increase
0 Mean +0 ml/
min/m2
-3 +7 +4.5
Mahjoub [50] 500 ml of 0.9%
saline over
20 minutes
Responders:
>10% SV
increase
0 Mean +1,000 ml/min -4 +7 +2.6
500 ml of 0.9%
saline over
20 minutes
Non-responders:
>10% SV
increase
0 Mean +300 ml/min -3 +1 +2.9
Monnet [53] 500 ml of 0.9%
saline over
10 minutes
All patients 0 Mean +800 ml/
min/m2
-7 +8 +5
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Monnet [55] 500 ml of 0.9%
saline over
20 minutes
Responders:
>15% CI
increase
0 Mean +800 ml/
min/m2
-2 +11
500 ml of 0.9%
saline over
20 minutes
Non-responders:
<15% increase
in CI
0 Mean +200 ml/
min/m2
-2 +4
Monnet [54] 500 ml of 0.9%
saline over
30 minutes
Responders:
>15% VO2
increase
0 Mean +1,000 ml/
min/m2
-2 +7 +1% -1.9 -7
500 ml of 0.9%
saline over
30 minutes
Non-responders:
<15% increase
in VO2
0 Mean +1,000 ml/
min/m2
+0 +13 +7% -0.3 -6
Schnell [62] 500 ml of 0.9%
saline over
15-30 minutes
Responders:
>10% increase
in aortic blood
flow
0 Median +20 ml/beat -10 +7
500 ml of 0.9%
saline over
15-30 minutes
Non-responders:
<10% increase in
aortic blood flow
0 Median +8 ml/beat -1 +6
Sturgess [63] 250 ml of 4%
albumin over
15 minutes
All patients 0 Mean +7.5%
ml/beat
Haemodynamic indices measured 30 minutes after fluid bolus administration
Freitas [40] 7 ml/kg,
maximum
500 ml, of 6%
HES over
30 minutes
Responders:
>15% CO
increase
30 Mean +2,100 ml/min -2 +11 +3 +8% -0.1
7 ml/kg,
maximum
500 ml, of 6%
HES over
30 minutes
Non-responders:
<15% increase
in CO
30 Mean +200 ml/min +0 +8 +5 -3.5% -0.2
Pierrakos [59] 500 ml of 6%
HES or 1,000 ml
of CSL over
30 minutes
Responders:
>10% increase
in CI
30 Mean +600 ml/
min/m2
-4 +8 +3 +3%
500 ml of 6%
HES or 1,000 ml
of CSL over
30 minutes
Non-responders:
<10% increase
in CI
30 Mean +0 ml/
min/m2
-4 +3 +2 +0%
Pottecher [60] Up to 500 ml
of 6% HES or
0.9% saline over
30 minutes
All patients 30 Mean +1,400 ml/min -2 +7
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Table 3 Physiological effects grouped by measurement time (Continued)
Wacharasint
[66]
500 ml of 6%
HES over
30 minutes
All patients 30 Mean +470 ml/
min/m2
+0.3 +9.2 +5.25
van Haren
[65]
250 ml of 6%
HES in 7.2%
saline over
15 minutes
Hypertonic bolus 30 Mean +300 ml/
min/m2
-11 +4 +2 -0.2 -8
500 ml of 6%
HES in 0.9%
saline over
15 minutes
Isotonic bolus 30 Mean -400 ml/
min/m2
-1 +5 +4 -0.1 -9
Haemodynamic indices measured 60 minutes after fluid bolus administration
Bihari [36] 500-750 ml of
4% albumin,
blood, 20%
albumin FFP,
0.9% saline, 4%
gelatin or
platelets
administered
over less than
30 minutes
All patients 60 Median +0 +2 +2 +0.4% -0.2 No
change
-6
Ospina-
Tascon [57]
400 ml of 4%
albumin or
1,000 ml of CSL
over 30 minutes
Patients with
early sepsis
60 Median +300 ml/
min/m2
+2 +2 +3 +2% -0.2
400 ml of 4%
albumin or
1,000 ml of CSL
over 30 minutes
Patients with
late sepsis
60 Median +300 ml/
min/m2
-9 +7 +1 +1% +0.1
van Haren
[65]
250 ml of 6%
HES in 7.2%
saline over
15 minutes
Hypertonic bolus 60 Mean +400 ml/
min/m2
-11 +6 +1 -0.3 -9
500 ml of 6%
HES in 0.9%
saline over
15 minutes
Isotonic bolus 60 Mean -300 ml/
min/m2
-1 +3 +3 -0.1 -12
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Table 3 Physiological effects grouped by measurement time (Continued)
Haemodynamic indices measured greater than 60 minutes after fluid bolus administration
van Haren
[65]
250 ml of 6%
HES in 7.2%
saline over
15 minutes
Hypertonic bolus 120 Mean +300 ml/
ml/m2
-7 +7 +2 0.0 +13 -6
500 ml of 6%
HES in 0.9%
saline over
15 minutes
Isotonic bolus 120 Mean -300 ml/
min/m2
+0 +1 +2 -0.3 -30 -9
250 ml of 6%
HES in 7.2%
saline over
15 minutes
Hypertonic bolus 180 Mean +100 ml/
min/m2
-3 +6 +3 -0.3 -9
500 ml of 6%
HES in 0.9%
saline over
15 minutes
Isotonic bolus 180 Mean +0 ml/
min/m2
+3 +5 +3 -0.2 -6
250 ml of 6%
HES in 7.2%
saline over
15 minutes
Hypertonic bolus 240 Mean +100 ml/
min/m2
+1 +3 +3 -0.3 -3 -8
500 ml of 6%
HES in 0.9%
saline over
15 minutes
Isotonic bolus 240 Mean -200 ml/
min/m2
+3 +0 +3 -0.2 -40 -4
CI, cardiac index; CO, cardiac output; CSL, compound sodium lactate; FFP, fresh frozen plasma; HES, hydroxyethyl starch; SVI, stroke volume index; VO2, oxygen delivery.
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Figure 4 Physiological effects of fluid bolus therapy over time. Multi-panel figure of the haemodynamic effects of fluid bolus therapy (FBT)
as reported in studies with observation periods of 60 minutes or more. (A) Changes in heart rate over time. (B) Changes in cardiac index over
time. (C) Changes in mean arterial pressure over time. (D) Changes in central venous pressure (CVP) over time. Each solid black line represents a
patient group and the average physiological response to FBT over the observation period. Lines terminate when measurements were discontinued in
the study from which the group was taken.
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http://ccforum.com/content/18/6/696changes. We found heterogeneity of triggers, amount,
fluid choice and speed of delivery for FBT, which was
administered to achieve heterogeneous physiological tar-
gets. We similarly found heterogeneity of physiological
changes after FBT. In addition, no RCTs compared FBT
with an alternative intervention. Finally, no study related
physiological changes after FBT to clinically relevant
outcomes.
FBT is a widespread intervention in the management
of the critically ill septic patient, despite lack of a con-
sistent definition or use of terminology. Our study dem-
onstrates that no contemporary RCTs exist that compare
FBT with alternative interventions. The only study com-
paring FBT to an alternative intervention was a single,
non-randomized, prospective, observational study that
compared acute circulatory failure patients treated with
FBT (500 ml of saline) or with increased norepinephrine
dose according to clinician preference. The two groups
had clearly different baseline characteristics and were
not directly compared [55]. Alternative interventions to
FBT may include a diagnostic low-volume FBT [17],
classic fluid challenge [11,12], low-volume FBT and low-
dose vasopressor therapy, or cardiac output-guided ther-
apy. Despite the availability of such strategies and the
availability of non-invasive cardiac output monitoring,
these alternative approaches have not been studied.Understanding which patient will be fluid responsive is
a vital part of rationalising fluid therapy [69]. However,
there are multiple different definitions of fluid respon-
siveness, each dependent on different interventions and
different measurements. It would appear that there is lit-
tle evidence to suggest a consistently different response
to FBT based on pre-intervention physiology, as fluid re-
sponsiveness is often tautologically and retrospectively
defined by participants ? responses to the therapy. A full
review of this topic is beyond the scope of this review,
though this information is available elsewhere [69,70].
The contribution of FBT to a positive fluid balance re-
mains poorly understood. In a recent observational
study, Bihari and colleagues [36] found that a median of
52.4% of fluid balance on the first, 30.8% on the second
and 33.2% on the third study day consisted of FBT. In
the Fluid and Catheter Treatment Trial [27] and Sepsis
Occurrence in Acutely Ill Patients [71] studies, increas-
ing fluid balance was associated with increased risk of
acute kidney injury and mortality. In a retrospective
study of septic shock patients in a North American uni-
versity hospital, non-survivors had a significantly greater
positive net fluid balance than survivors over the first
24 hours from onset [34]. Our study also shows little or
no evidence for any persisting beneficial physiological
changes following FBT. These observations suggest the
Table 4 Clinically orientated primary outcomes
First author Journal Year Control group ICU mortality Hospital
mortality
Other Intervention group ICU
mortality
Hospital
mortality
Other
MacRedmond [49] Quality and Safety
in Health Care
2010 Before protocolised
resuscitation
19/37 After protocolised resuscitation 10/37
Pierrakos [59] Intensive Care
Medicine
2012 Responders (>10%
increase in CI)
13/25 Non-responders (<10%
increase in CI)
11/26
Patel [58] Annals of
Pharmacotherapy
2010 Pre-intervention 32/53 Post-intervention, significantly
more fluid and less vasoactives
12/59
Castellanos-Ortega [37] Critical Care
Medicine
2010 Pre-intervention 51/96 55/96 Post-intervention, significantly
more fluid
117/384 144/384
Trof [64] Critical Care
Medicine
2012 Pulmonary artery catheter-
guided resuscitation
13/34 15/34 Transpulmonary thermodilution-
guided resuscitation
17/38 21/38
Hanzelka [43] Supportive Care in
Cancer
2013 Pre-intervention 28-day: 38/100 Post-intervention, significantly
quicker resuscitation
28-day: 20/100
Jacob [44] Critical Care
Medicine
2012 Pre-intervention 30-day: 126/245 Post-intervention, significantly
quicker resuscitation with
significantly larger volumes of
fluid at 6 and 24 hours
30-day: 257/426
CI, cardiac index.
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Table 5 Clinically orientated secondary outcomes
First author Journal Year Control group LOS in ICU
(days)
LOS in hospital
(days)
MV
(days)
CRRT Intervention group LOS in ICU
(days)
LOS in hospital
(days)
MV
(days)
CRRT
MacRedmond
[49]
Quality and Safety in
Health Care
2010 Before protocolised
resuscitation
8 After protocolised resuscitation 7
Castellanos-
Ortega [37]
Critical Care Medicine 2010 Pre-intervention 9.9 26.5 Intervention group, significantly
more receive fluid
9.1 30.6
Hanzelka [43] Supportive Care in
Cancer
2013 Pre-intervention 5.1 10.3 Post-intervention, significantly
quicker resuscitation
2.5 8.1
Trof [64] Critical Care Medicine 2012 Pulmonary artery
catheter-guided
resuscitation
15 25 13 Transpulmonary thermodilution-
guided resuscitation
11 27 10
Patel [58] Annals of
Pharmacotherapy
2010 Pre-intervention 6 9.5 7.5 8/53 Post-intervention, significantly
more fluid and less vasoactives
5 9 7 0/59
CRRT, continuous renal replacement therapy; LOS, length of stay; MV, mechanical ventilation.
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http://ccforum.com/content/18/6/696need for RCTs comparing FBT with alternative interven-
tions and well-defined triggers and physiological outcomes.
This review has several strengths. To our knowledge
this is the first review of the contemporary literature on
FBT in critically ill patients with severe sepsis.
We are the first to explore the contemporary features
of a FBT, and the first to produce a summary of the
physiological changes associated with FBT in septic, crit-
ically ill patients, including data from RCTs, and obser-
vational and quasi-experimental studies. Our wide
search criteria, use of three separate sources and hand
searching references reduced the risk of inclusion bias
and makes it unlikely that we missed relevant studies.
Our study also has some limitations. Our assessments
of physiological changes are necessarily limited to the
measures of central tendency provided in tables and
graphs in the studies identified. We have only provided
crude median results in an attempt to provide a rough
estimate of possible effect. We limited our search to the
present evolving decade. It is unlikely that current clin-
ical practice is better reflected by earlier studies. Indeed,
in comparing our results with similar, earlier studies, the
reported physiological changes are similar [14,71-75].
We did not account for the effect of vasoactive medications
beyond noting their administration. It appears obvious that
the mixed and differential inotropic/vasopressor/lusitropic/
chronotropic effects of different vasoactive medications are
likely to have an effect on the physiological changes re-
ported, as would the administration of blood products.
Inadequate information was provided in the studies to
make such adjustments possible. FBT is normally part of a
complex intervention - the resuscitation of the critic-
ally ill patient. As well as the initiation and manipula-
tion of vasoactive medications, analyses must contend
with the impact of the use of mechanical ventilation,
CRRT, and antibiotic administration. These con-
founders were not reliably reported in the studies
identified and could not be evaluated. In addition, the
perceived haemodynamic success of an intervention
often depends on the trajectory of the patient ? s clinical
course. Unfortunately no such information was avail-
able from the studies reviewed.
Conclusion
FBT in severe sepsis and septic shock is described in 33
articles in the contemporary literature. Only 17 of these
studies report the physiological changes associated with
FBT. Evidence regarding the efficacy of FBT compared
with alternative interventions is lacking. Crucially, no
studies relate the physiological changes after FBT to
clinically relevant outcomes. In light of recent studies
highlighting the association between FBT and fluid ad-
ministration in general and harm, there is a clear need
for at least obtaining randomised controlled evidence forthe physiological effects of FBT over the immediate (0 to
4 hours) post-intervention period in patients with severe
sepsis and septic shock.
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